Geratherm Medical AG, a medical technology company, develops, produces, and markets medical products for measuring vital data in Germany. It operates through Healthcare Diagnostic, Respiratory, and Incubator Systems segments. The Healthcare Diagnostic segment offers medical temperature measurement products, including mercury-free glass fever thermometer. Its Respiratory segment develops, produces, and sells lung function measuring devices. The Incubator Systems segment offers MRI-compatible incubators for premature infants. The company markets its products through pharmacies, hospitals, and clinics. It exports its products to approximately 60 countries. The company was founded in 1990 and is headquartered in Geschwenda, Germany.
Frequently asked questions
What sector does Geratherm Medical AG (GME) operate in?
Geratherm Medical AG belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Geratherm Medical AG (GME) current stock price?
As of the latest data, Geratherm Medical AG stock price is €2.22, with a previous close of €2.24. Geratherm Medical AG lost -€0.02 in the last trading session, representing a -0.89% loss.
What is Geratherm Medical AG (GME) current market capitalization?
Geratherm Medical AG market cap is approximately 12.01 million.
What is Geratherm Medical AG (GME) Earnings Per Share (EPS)?
The trailing EPS is -€0.19, and the forward EPS is €0.02.
What is Geratherm Medical AG (GME) EBITDA?
Geratherm Medical AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 58.96 thousand.
Does Geratherm Medical AG (GME) pay dividends?
Yes. Geratherm Medical AG pays annual dividends with an annualized yield of 4.5% and an estimated annual payout of €0.10 per share.
When is the next ex-dividend date for Geratherm Medical AG (GME)?
The next ex-dividend date is scheduled for July 27, 2027.
What is Geratherm Medical AG (GME) beta (volatility) score?
Geratherm Medical AG has a beta of 0.439, indicating lower volatility than the overall market.
